References
Bornstein MB, Miller AI, Teitelbaum D, et al (1982) Multiple sclerosis: trial of a synthetic polypeptide. Ann Neurol 11: 317–319
Bornstein MB, Miller A, Slagle S, et al (1987) A pilot trial of Cop 1 in exacerbating-remitting multiple sclerosis. N Engl J Med 317:408–414
Bornstein MB, Miller A, Slagle S, et al (1991) A placebo-controlled, doubleblind, randomized, two-center, pilot trial of Cop 1 in chronic progressive multiple sclerosis. Neurology 41:533–539
Johnson KP, Brooks BR, Cohen JA, et al (1995) Copolymer 1 reduces relapse rate and improves disability in relapsing-remitting multiple sclerosis: results of a phase III multicenter, double-blind, placebo-controlled trial. Neurology 45:1268–1276
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Johnson, K.P. Introduction. J Neurol 243 (Suppl 1), S1–S2 (1996). https://doi.org/10.1007/BF00873694
Issue Date:
DOI: https://doi.org/10.1007/BF00873694